RP Bio Inc. (KOSDAQ:314140)

RP Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	56,331	43,765	74,964	102,515	-	-
Market Cap Growth	-45.32%	-41.62%	-26.88%	-	-	-
Enterprise Value	64,317	58,375	92,754	118,331	-	-
Last Close Price	6500.00	5050.00	8650.00	12474.49	-	-
PE Ratio	43.03	-	13.79	23.75	-	-
PS Ratio	0.45	0.35	0.50	0.74	-	-
PB Ratio	0.54	0.43	0.73	1.13	-	-
P/TBV Ratio	0.55	0.43	0.73	1.13	-	-
P/FCF Ratio	6.14	5.71	-	-	-	-
P/OCF Ratio	3.48	3.24	7.09	88.76	-	-
EV/Sales Ratio	0.51	0.47	0.61	0.86	-	-
EV/EBITDA Ratio	7.85	9.53	7.32	7.86	-	-
EV/EBIT Ratio	46.84	-	14.01	12.27	-	-
EV/FCF Ratio	7.01	7.61	-	-	-	-
Debt / Equity Ratio	0.25	0.30	0.30	0.42	0.59	0.63
Debt / EBITDA Ratio	3.18	4.93	2.43	2.54	3.64	4.68
Debt / FCF Ratio	2.84	3.94	-	-	18.23	-
Asset Turnover	0.77	0.76	0.89	0.87	0.84	0.78
Inventory Turnover	4.20	4.02	3.73	3.94	5.24	5.85
Quick Ratio	0.73	0.71	0.57	0.50	0.41	0.40
Current Ratio	1.23	1.19	1.18	1.03	0.73	0.66
Return on Equity (ROE)	1.27%	-0.89%	5.61%	5.39%	5.73%	7.68%
Return on Assets (ROA)	0.53%	-0.27%	2.44%	3.81%	2.68%	2.07%
Return on Capital (ROIC)	0.64%	-0.33%	3.15%	5.05%	3.44%	2.63%
Return on Capital Employed (ROCE)	1.20%	-	6.10%	10.20%	8.10%	6.40%
Earnings Yield	2.32%	-2.07%	7.25%	4.21%	-	-
FCF Yield	16.29%	17.53%	-0.73%	-3.89%	-	-
Buyback Yield / Dilution	21.14%	7.41%	-31.19%	-8.34%	1.16%	-1.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.